Drug
Asedebart
Asedebart: highest development phase Phase 2, developed by Lundbeck. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Lundbeck
Trials
| Drug | Phase | Indication |
|---|---|---|
| Asedebart NCT07859293 | Phase 2 | Adrenal Hyperplasia, Congenital |
Latest
No recent events.
Follow Asedebart on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.